涉及意识障碍患者的临床试验优化设计
Curing Coma Campaign临床试验工作组对涉及意识障碍(DoC)患者的临床试验进行缺口分析,分为三个亚组:审查现有试验、识别设计独特挑战、推荐优化设计。共筛选3055项研究,纳入66项。结果发现缺乏高质量临床试验,多数数据基于关注创伤性脑损伤和心脏骤停患者的观察性研究;缺乏结构化长期结局评估,方法学、结局定义和研究实施异质性显著,尤其长期随访;另一主要障碍是资源缺乏,尤其是低收入国家。基于现有数据,工作组推荐采用主方案、序贯多重评估随机试验和比较效果研究;使用多臂多阶段自适应平台试验具有实质优势,并应利用生物标志物评估治疗反应以提高试验效率;健全的基础设施和国际合作至关重要。
要点
- 共筛选3055项研究,仅66项纳入审查,意识障碍领域缺乏高质量临床试验。
- 现有数据多基于观察性研究,聚焦创伤性脑损伤和心脏骤停患者。
- 缺乏结构化长期结局评估,方法学、结局定义和研究实施异质性显著,尤其长期随访。
- 资源缺乏是开展临床试验的另一主要障碍,尤其是低收入国家。
- 工作组推荐采用主方案、序贯多重评估随机试验和比较效果研究;多臂多阶段自适应平台试验具实质优势,应利用生物标志物评估治疗反应以提高试验效率。
适用人群与场景
- 涉及意识障碍(DoC)患者的研究人群;现有数据多来自创伤性脑损伤和心脏骤停患者。
研究设计与关键结果
- Curing Coma Campaign临床试验工作组分为三个亚组:(1)审查涉及DoC患者的临床试验;(2)识别涉及DoC患者临床试验设计的独特挑战;(3)推荐DoC的优化临床试验设计。
- 共筛选3055项研究,66项纳入本审查。
- 识别出若干知识缺口和独特挑战:缺乏高质量临床试验,多数关于DoC患者的数据基于关注创伤性脑损伤和心脏骤停患者的观察性研究。
- 缺乏结构化长期结局评估,方法学、结局定义和研究实施异质性显著,尤其长期随访。
- 开展临床试验的另一主要障碍是资源缺乏,尤其是低收入国家。
- 基于现有数据,工作组推荐纳入使用主方案、序贯多重评估随机试验和比较效果研究的试验设计。
- 使用多臂多阶段方法的自适应平台试验提供实质优势,应利用生物标志物评估治疗反应以提高试验效率。
- 健全的基础设施和国际合作对于促进DoC患者试验的实施至关重要。
证据类型、等级与局限
- 证据类型:工作组缺口分析(综述性文件);局限性:原文未报告局限性。
对床旁实践的改变
- 作者认为,DoC患者的试验实施应利用主方案和自适应设计,并建立纳入标准化评估工具的国际注册登记。
- 作者认为,这将有助于建立基于证据的实践推荐并减少诊疗差异。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Limited data exist regarding the optimal clinical trial design for studies involving persons with disorders of consciousness (DoC), and only a few therapies have been tested in high-quality clinical trials. To address this, the Curing Coma Campaign Clinical Trial Working Group performed a gap analysis on the current state of clinical trials in DoC to identify the optimal clinical design for studies involving persons with DoC.
METHODS: The Curing Coma Campaign Clinical Trial Working Group was divided into three subgroups to (1) review clinical trials involving persons with DoC, (2) identify unique challenges in the design of clinical trials involving persons with DoC, and (3) recommend optimal clinical trial designs for DoC.
RESULTS: There were 3055 studies screened, and 66 were included in this review. Several knowledge gaps and unique challenges were identified. There is a lack of high-quality clinical trials, and most data regarding patients with DoC are based on observational studies focusing on patients with traumatic brain injury and cardiac arrest. There is a lack of a structured long-term outcome assessment with significant heterogeneity in the methodology, definitions of outcomes, and conduct of studies, especially for long-term follow-up. Another major barrier to conducting clinical trials is the lack of resources, especially in low-income countries. Based on the available data, we recommend incorporating trial designs that use master protocols, sequential multiple assessment randomized trials, and comparative effectiveness research. Adaptive platform trials using a multiarm, multistage approach offer substantial advantages and should make use of biomarkers to assess treatment responses to increase trial efficiency. Finally, sound infrastructure and international collaboration are essential to facilitate the conduct of trials in patients with DoC.
CONCLUSIONS: Conduct of trials in patients with DoC should make use of master protocols and adaptive design and establish international registries incorporating standardized assessment tools. This will allow the establishment of evidence-based practice recommendations and decrease variations in care.
参考来源
- Cho SM, Robba C, Diringer MN, et al. Optimal Design of Clinical Trials Involving Persons with Disorders of Consciousness. Neurocrit Care. 2023. PMID: 37535178. doi:10.1007/s12028-023-01813-2
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。